Nobody bought this stock due to Aegis and nobody sold due to them. Somebody asked what the updated report said. That simple. They see the same thing the chief science officer of the Alzheimer's association saw, and that's a trend toward better cognition in late stage alzheimer's patients, a trend that apparently held for an additional month after the endpoint of the study in patients who went for the month followup according to the abstract. All of which was presented in London of course. JMHO
News 
Market Data 
Discover 
